Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The melanosomal transfer machinery is a complex biological system responsible for the movement of melanin-containing organelles, called melanosomes, from melanocytes to neighboring keratinocytes in the epidermis. This process is essential for skin pigmentation and photoprotection against ultraviolet radiation (PMID: 12185071). The machinery involves a tripartite protein complex consisting of Rab27a, Melanophilin (MLPH), and Myosin Va (MYO5A), which facilitates the transport of melanosomes along actin filaments to the melanocyte dendrites (PMID: 11748271). Once at the periphery, the transfer to keratinocytes is mediated by mechanisms such as membrane fusion, exocytosis, or phagocytosis, the latter of which is significantly regulated by the Protease-activated receptor 2 (PAR2) on keratinocytes (PMID: 10844477). Dysregulation of this machinery is a primary driver of hyperpigmentary disorders like melasma and solar lentigo, while genetic mutations in its core components lead to Griscelli syndrome. Pharmacological intervention often targets this machinery using agents like niacinamide, which inhibits the transfer process, or PAR2 inhibitors to reduce visible pigmentation without necessarily affecting melanin synthesis itself (PMID: 12100180).
Inhibition of melanosome transfer from melanocytes to keratinocytes by blocking PAR2-mediated phagocytosis or disrupting the Rab27a-Melanophilin-Myosin Va transport complex.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanosomal transfer machinery.